Background
Mating of haploid cells of the budding yeast Saccharomyces cerevisiae is regulated by a mitogen-activated protein (MAP) kinase cascade that is activated by the binding of peptide pheromone to a serpentine receptor. The activated receptor causes an inhibitory Gα subunit to dissociate from a Gβ-Gγ dimer of a heterotrimeric G protein [1, 2] . The Gβ-Gγ subunits propagate the signal through the PAK kinase Ste20 [3] [4] [5] , possibly through a direct interaction [6, 7] . Ste20 is thought to activate the MAP kinase (ERK) kinase kinase (MEKK) Ste11, on the basis of epistasis tests that place Ste20 before Ste11 in the pathway [3, 4] . Phosphorylation of Ste11 by Ste20 in vitro does not alter Ste11 activity [8] , suggesting that other proteins are required. Ste11 activates the MEK (MAP kinase kinase) Ste7 [9] , and Ste7 activates two functionally redundant MAP kinases, Fus3 and Kss1 [10] . These MAP kinases promote many responses including gene activation, cell cycle arrest in the G1 phase, morphogenesis, and cell fusion. These responses are thought to arise by the direct phosphorylation of multiple targets by the MAP kinases [11] [12] [13] [14] [15] .
Activation of Ste11 by the Gβ subunit of the G protein (encoded by the STE4 gene) requires two other proteins, Ste50 and Ste5. Ste50 regulates Ste11 by an unknown mechanism and is not essential for signal transduction [16] . Ste5 is essential for signaling and has multiple functions [17] . Ste5 has been proposed to act as a scaffold that colocalizes Ste11, Ste7 and Fus3/Kss1 [18] [19] [20] . Ste5 has separable binding domains for each of the kinases that binds it [19] , and tethers them into a high molecular weight complex [19] of high specific activity (J.A. Kranz, S.M. Mahanty and E.A.E., unpublished observations). This complex may facilitate signal transmission from Ste11 to Fus3 as well as feedback phosphorylation of upstream components [17] . Ste5 also interacts with regulators of morphogenesis and G1 arrest and may localize the MAP kinase cascade to substrates involved in these outputs [21, 22] . Ste5 may directly regulate Ste11; its overexpression is sufficient to activate Ste11 in the absence of a signal [19] and it associates with the regulatory domain of Ste11 [19, 20] which is known to be inhibitory [23] . A gain-of-function mutation located within this regulatory domain (STE11-1) [24] increases the ability of Ste11 to interact with Ste5 in a two-hybrid system [25] .
Ste5 associates with Gβ through its amino-terminal 214 amino acids [26] , suggesting that a Gβ-Ste5 interaction is required for signal transmission. Ste5 oligomerizes through two regions [27] , one of which may overlap a bipartite metal-binding motif which resembles a LIM domain [17] . While not identical to a LIM domain, for simplicity we will refer to this motif as a LIM domain. LIM domains mediate homodimeric and heterodimeric interactions in many proteins including transcription factors and cytoskeletal proteins implicated in signaling [28] . Ste5 oligomerization has been proposed to be essential for signal transduction [27] and to require the LIM domain [29] . The LIM domain of Ste5 (residues 177-229) partially overlaps residues 1-214, which have been implicated in Gβ binding, raising the possibility that Gβ binding might involve the LIM domain and affect Ste5 oligomerization.
Here, we report the analysis of a Ste5 point mutant which shows that the functional binding of Gβ to Ste5 through the putative LIM domain of Ste5 is required for pheromone-dependent activation of the MEKK Ste11. This function is distinct from the ability of Ste5 to oligomerize or to serve as a scaffold. Additional results suggest that the Ste5-Gβ interaction may be pheromone dependent. Ste5 is preferentially associated with a phosphorylated form of Gβ whose accumulation is dependent on pheromone, and the kinase that catalyzes this phosphorylation is dependent on Ste5. Phosphorylation of Gβ in the presence of pheromone may be a molecular 'tag' for the activated form of Gβ.
Results
The ste5C180A mutant behaves phenotypically like a ste5 null mutant We generated a cysteine to alanine point mutation at residue 180 of Ste5 (Ste5C180A); this residue is within the first of the two predicted zinc fingers that comprise the LIM domain as well as the first 214 amino acids of Ste5, which associate with Gβ [30] . The ste5C180A mutant was sterile in a qualitative patch mating assay, like a ste5∆ null mutant ( Figure 1a) ; ste5C180A was also completely defective in pheromone-induced responses such as transcriptional activation, G1 arrest, and morphological changes. We used a β-galactosidase reporter gene under the control of the FUS1 promoter (FUS1-LACZ) as a reporter for pathway activity in ste5C180A. In contrast to wild-type cells, FUS1 expression was not induced at all by α factor in the ste5C180A mutant and remained at the same low levels as in the ste5∆ null strain ( Table 1) . The ste5C180A mutant did not undergo G1 arrest, as shown by persistent growth in the presence of α factor (Figure 1b ) and the absence of unbudded cells with projections (termed shmoos; data not shown). This complete absence of function did not seem to be due to destabilization of the protein as the abundance of Ste5C180A was similar to that of Ste5 (Figure 1c) . Thus, cysteine 180 is essential for the activity of Ste5 with respect to all aspects of signaling measured.
Ste5C180A is able to associate with Ste11, Ste7 and Fus3
To understand the nature of the signaling defect of ste5C180A, we tried to pinpoint the block in signal transduction. We first tested the ability of the mutant protein to function as a scaffold for the kinases on the MAP kinase pathway. Two-hybrid analysis showed that the Ste5C180A protein was able to associate with Ste11, Ste7 and Fus3 (Table 2 ). Fus3 interacted nearly equally well with Ste5C180A as it did with wild-type Ste5. Ste11 and Ste7 also interacted efficiently with Ste5C180A, but at somewhat lower levels than they did with wild-type Ste5. A simple reduction in the level of interaction with Ste11 and Ste7 cannot account for the complete block in signaling, because overexpression of Ste5C180A (by introduction of the ste5C180A gene on a two micron (2µ) plasmid) did not 268 Current Biology, Vol 8 No 5
Figure 1
The ste5C180A mutant behaves like a ste5 null mutant. (a) Sterility of ste5C180A in a patch mating assay. Strain EY1775 (ste5∆) containing either the CEN URA3 plasmid alone (vector) or this plasmid harboring either STE5 or ste5C180A was mated for 5 h at 30°C on YPD (yeast extract peptone dextrose medium), before replica-plating to a YNB (yeast nitrogen base medium) plate to select for diploids. (b) The ste5C180A mutant is α-factor resistant. The same strains as in (a) were tested in halo assays using 3 µl 167 µM α factor. (c) Ste5C180A protein is as abundant as wild-type Ste5. Immunoblot of extracts prepared from EY1775 strains containing CEN URA3 plasmids harboring genes encoding Ste5 or Ste5C180A tagged with three copies of the Myc epitope (STE5-Myc3 and ste5C180A-Myc3). Whole cell extracts (30 µg) were loaded in both lanes. The immunoblot was probed with the anti-Myc monoclonal antibody 9E10. rescue the absence of function in a ste5 null mutant (data not shown). Thus, the mutant protein is able to associate with all three kinases -Ste11, Ste7 and Fus3 -suggesting that its strong defect in signal transduction is at another step of signal transmission.
Ste5C180A is able to basally activate Ste11 and facilitate signal transmission to the MAP kinases
If the Ste5C180A protein retains scaffolding functions, then it should be able to positively regulate the basal activity of Ste11 and allow signaling from Ste11 through Ste7 to Fus3. We first tested this by determining whether the ste5C180A mutant retains the ability to positively regulate a constitutively hyperactive allele of STE11, STE11-4, in the absence of mating pheromone. The STE11-4 gene encodes a protein with a single amino acid change in the catalytic domain that significantly raises the basal activity of Ste11 as quantitated by expression of the FUS1 gene [24] . Full basal activity of STE11-4 requires a functional Ste5 protein, because a ste5∆ STE11-4 strain has only 10% of the level of FUS1 expression present in a STE5 STE11-4 strain [24] . Mutations in either Gβ or the pheromone receptor have no effect on constitutive activation of FUS1 by STE11-4, while mutations in either STE7 or FUS3 and KSS1 block activation [24] . Thus, the level of basal FUS1 expression in a ste5C180A STE11-4 strain provides a sensitive means to monitor whether the Ste5C180A protein can positively regulate Ste11 and can transmit its signal to the MAP kinases. Ste5C180A enhanced the basal activity of the Ste11-4 protein, as shown by three-fold higher levels of constitutive FUS1 expression (Table 1 , -α factor column), and restored mating in the ste5C180A STE11-4 strain compared with the ste5∆ STE11-4 strain (Figure 2a ). This result strongly argues that Ste5C180A retains the ability to bind to and positively regulate Ste11.
Additional experiments using a fusion protein of glutathione-S-transferase (GST) and Ste5C180A also argue that the Ste5C180A protein facilitates Ste11 function.
For reasons that are not yet clear, the addition of GST to
Research Paper A pheromone-dependent Ste5-Gb interaction activates Ste11 Feng et al. 269 Table 1 The ste5C180A mutant does not respond to a factor but does activate STE11-4 to a basal level. The response to α factor was assessed by measuring the β-galactosidase activity in cells expressing a FUS1-LACZ reporter gene. The ste5∆ strain (EY1775) contained FUS1-LACZ (pJB207) and centromeric (CEN) plasmids either alone or harboring STE5 (pYBS138) or ste5C180A (pEK1). The STE11-4 strain (S74) contained FUS1-LACZ (pJB207) and the two micron (2µ) plasmid either alone or harboring STE5 (pSCEM20) or ste5C180A (pSCEM22). STE11-4 ste20∆ strain EY1981 contained FUS1-LACZ (pJB207) and YCplac195. Strains were grown to an A 600 of ~0.4 at 30 o C and induced by adding either 50nM α factor (+ α factor) or an equal volume of 90% methanol (-α factor) for 90 min. For the glutathione-S-transferase (GST) fusion proteins GST-Ste5 and GST-Ste5C180A, the ste5∆ strain EY1775 containing FUS1-LACZ (pSB231) and GST-STE5 (pYEE170), GST-ste5C180A (pLS29) or GST (pYEE161) was pregrown in raffinose medium to an A 600 of ~0.6. Cells were pelleted, resuspended in galactose medium at an A 600 of 0.2, grown for 4 h and then induced as above. Extracts were prepared and assayed for β-galactosidase activity as described in Materials and methods. Results are shown as the mean ± the standard deviation for four transformants. Strains expressing GST fusion proteins had the CEN FUS1-LACZ plasmid while all other strains had the 2µ FUS1-LACZ plasmid. wild-type Ste5 greatly enhances the activity of Ste5 as measured by mating and activation of Fus3 kinase [18] . GST-Ste5 is able to fully activate Fus3 and complement the mating defect of a ste5 null mutant under conditions in which GST-Ste5 is expressed at levels too low to detect (when it is under the control of a repressed GAL1 promoter). This GST-Ste5 fusion is likely to be a gainof-function derivative of Ste5 because it constitutively induces the expression of the FUS1-LACZ reporter gene under the conditions of negligible expression (data not shown). GST also enhanced the activity of Ste5C180A, shown by an enhancement in the basal signaling from the FUS1-LACZ reporter (Table 1 ). This enhanced basal signaling was associated with a weak mating capacity (Figure 2b) . Strikingly, overexpression of either Ste11 or Ste7 greatly enhanced the ability of the strain expressing GST-Ste5C180A to mate, contrasting the absence of an effect in the ste5∆ null strain (Figure 2b ). Taken together, the results argue compellingly that Ste5C180A facilitates both Ste11 activation of Ste7 and Ste7 activation of the MAP kinases. This is consistent with the twohybrid results showing that Ste5C180A is able to function as a scaffold.
The ste5C180A mutant is blocked at the Gb and Ste20 steps of pheromone-dependent activation of Ste11
We determined whether Ste5C180A is defective in transmitting an activating signal to Ste11 from an upstream component. Gβ, Ste20 and Ste50 have been positioned upstream of Ste5 and Ste11 and are thought to positively regulate its activity. Overexpression of Gβ (encoded by the STE4 gene), Ste20 and Ste50 stimulated signal transduction in a wild-type strain, but did not bypass the signal transduction defect of the ste5C180A mutant as assayed by mating (Figure 3a) , transcriptional activation of a HIS3 reporter gene driven by the FUS1 promoter (FUS1-HIS3; Figure 3b , data shown for Gβ and Ste20 only), and G1 arrest ( Figure 3c , data shown for Gβ only). This block in signal transduction was very tight. Despite a high level of basal activation of FUS1 in the ste5C180A STE11-4 double mutant, this strain did not respond to α factor, as shown by the absence of an increase in FUS1-LACZ expression levels ( Table 1 , + α factor column) and the absence of G1 arrest ( Figure 2c ). The ability of this strain to mate ( Figure 2a ) is therefore due to the high level of constitutive functioning of the Ste11-4 protein, rather than to a pheromone-dependent event. Overexpression of Gβ, Ste20 or Ste50 did not increase the mating of the STE11-4 ste5C180A strain (Figure 3a) , and overexpression of Gβ did not increase the mating of the GST-Ste5C180A strain (data not shown). The fact that excess Gβ, Ste20 and Ste50 had no effect in the STE11-4 ste5C180A strain contrasts their ability to enhance signaling in a STE11-4 STE5 strain (V. Cherkasova, D.M. Lyons and E.A.E., unpublished observations). Thus, ste5C180A is tightly blocked for a pheromone-dependent event that requires both Gβ and Ste20 and occurs at or upstream of Ste11.
An intact Ste5 LIM domain is sufficient to bind to Gb and blocks Gb-mediated signaling when overexpressed
We tested whether the LIM domain of Ste5 mediates the interaction with Gβ, and whether the ste5C180A mutation Table 2 Ste5C180A is severely defective in its interaction with Gb but not with Ste11, Ste7, Fus3 or Ste5.
B42
B42-Ste5 B42-Ste5C180A LexA-Ste11 0.5 ± 0.1 703 ± 129 296 ± 48 LexA-Ste7 9.34 ± 1.5 728 ± 106 288 ± 50 LexA-Fus3
1.27 ± 0.5 45.1 ± 9.1 37.0 ± 10.7 LexA-Gβ 33043 ± 5521 77711 ± 13690 24414 ± 3939
Two-hybrid analysis was performed using LexA and B42 fused to intact proteins or the regions encompassed by the amino acid residues indicated. Most two-hybrid interactions were analyzed in strain AMR70. LexA-Gβ was assayed in a ste11∆ fus3∆ strain (EY1453) with the LexAop-LACZ LEU2 two micron (2µ) plasmid (pYEE158) to avoid constitutive pathway activation by ADHpLexA-Ste4.
Ste5 oligomerization was assayed in an a/α diploid (from a cross between AMR70 and EY698 [11] ). Cells were grown and lysates prepared and assayed for β-galactosidase activity as described in Materials and methods. The results are shown as the mean ± the standard deviation and are the average from four transformants.
abolishes this interaction. As shown by two-hybrid analysis, a B42-Ste5C180A fusion protein did not interact at all with a LexA-Gβ fusion protein, in contrast to an obvious ability of B42-Ste5 to interact with LexA-Gβ (Table 2) , suggesting that Ste5C180A is defective in binding to Gβ. Coimmunoprecipitation experiments recapitulated these two-hybrid results. A Myc-epitope-tagged fragment (amino acids 1-242) of Ste5, Ste5(1-242), co-purified with a functional hemagglutinin (HA)-epitope-tagged Gβ from yeast whole cell extracts, while the same fragment harboring the C180A mutation was defective ( Figure 4a ). Taken together the data strongly argue that the LIM domain mediates the interaction between Ste5 and Gβ, and provide a possible explanation for the null phenotype of ste5C180A.
Two-hybrid tests of three amino-terminal Ste5 fragments that span the LIM domain show that an intact LIM
domain is essential for binding to Gβ (Table 2) . A LexA-Ste5(1-176) fusion, which lacks the LIM domain, did not interact with a B42-Gβ fusion. By contrast, LexA-Ste5(1-214) and LexA-Ste5(1-230) fusions, which span the LIM domain, interacted with B42-Gβ. While this analysis is complicated by the fact that the LexA-Ste5(1-230) fusion activated transcription at the LexA operator in the absence of an interaction, it is clear that more interaction was detected with B42-Gβ than with B42. The introduction of the C180A mutation into LexA-Ste5(1-214) and LexA-Ste5(1-230) abolished their ability to interact with B42-Gβ. This absence of an interaction is unlikely to be due to a gross conformational change, because both LexA-Ste5C180A(1-214) and LexA-Ste5C180A(1-336) efficiently interacted with B42-Ste5 ( Table 2) .
We tested whether an interaction between the Ste5 fragments and Gβ correlated with function, by determining whether the fragments would interfere with Gβ-mediated signaling when overexpressed. As shown in Figure 5 , the two-hybrid results predicted whether or not the aminoterminal fragments inhibited Gβ-mediated signaling. Ste5(1-176), which did not interact with Gβ, had no effect on α-factor-induced G1 arrest. By contrast, both Ste5 fragments that overlap the LIM domain efficiently blocked G1 arrest in wild-type cells and STE11-4 cells, with better inhibition by the fragment with a complete LIM domain. Moreover, neither of the C180A derivatives of these fragments blocked signaling. Thus, the LIM domain is necessary and sufficient to inhibit Gβ-mediated signaling when overexpressed, and this inhibition correlates with binding to Gβ.
Overexpression of a LIM domain blocks Ste20-independent signal transmission
Previous work suggests that Gβ activates Ste11 by two mechanisms, one that is dependent upon Ste20 catalytic activity, and one that is distinct. First, a ste20∆ deletion strain is not fully sterile [6] . Second, a STE11-4 ste20 double mutant undergoes pheromone-induced G1 arrest and enhancement in Fus3 activity (Figure 2c ) [21] and FUS1 expression (Table 1 ). This bypass does not occur in STE11-4 ste4∆ or STE11-4 ste5∆ double mutants [21] , arguing that Gβ mediates signal transduction through Ste20 and a less essential auxiliary pathway of signaling that requires Ste5 [21] . The LIM domain seems to be required for this auxiliary pathway of signaling for two reasons; first, STE11-4 did not bypass the pheromonedependent block of a ste5C180A mutant, although it did bypass the ste20∆ mutant (Table 1, Figure 2c ). Second, overexpression of the set of Ste5 fragments that block G1 arrest in a wild-type strain also block G1 arrest in a STE11-4 ste20∆ strain ( Figure 5 ). Thus, the LIM domain is required for this parallel pathway of signaling that operates in the absence of Ste20.
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Figure 3
Overexpression of Gβ, Ste20 and Ste50 does not suppress ste5C180A. (a) Overexpression of Gβ, Ste20 and Ste5 does not restore mating to ste5C180A. The ste5∆ strain (EY1775) containing CEN URA3 STE5 (pYBS138), CEN URA3 ste5C180A (pEK1) or vector alone was transformed with GAL1p-STE4 (pYEE116), GAL1p-STE20 (ZM44STE20), or GAL1p-STE50 (ZM44STE50), respectively. Transformants were tested for patch mating on YEP plates containing 2% galactose as described in Figure 1a .
(b) GAL1p-STE4
and GAL1p-STE20 do not restore FUS1 expression to ste5C180A. A ste5∆ far1∆ his3 ∆200 strain with FUS1-HIS3 integrated at the LYS2 locus (EY2019) was co-transformed with CEN plasmids harboring STE5 (pYBS138), ste5C180A (pEK1) or vector control and either GAL1p-STE4 (pL19) or GAL1p-STE20 (ZM44STE20).
GAL1p-STE4 transformants were tested for growth on SC selective plates containing galactose and lacking histidine. GAL1p-STE20 transformants were tested in the same way, except that the plate also contained enough α factor to stimulate expression of FUS1-HIS3, but not G1 arrest, in the presence of STE5. (c) GAL1p-STE4 does not induce growth arrest in ste5C180A. The transformants described in (a) were streaked on SC selective plates containing 2% dextrose (Dex) or 2% galactose (Gal) and incubated at 30°C.
Ste5C180A is defective in binding to Gb
To detect a possible physiological defect in binding between Gβ and Ste5C180A in vivo, we first characterized the interaction between wild-type Ste5 and Gβ using functional tagged versions of Ste5 and Gβ (Ste5-Myc9 and HA-Gβ). HA-Gβ was expressed from the GAL1 promoter for various lengths of times, with or without subsequent repression of the promoter (Figure 4b) , and Ste5-Myc9 was expressed from its own promoter on a lowcopy centromere plasmid or on a high-copy 2µ plasmid. Reasonable levels of specific binding between HA-Gβ and Ste5-Myc9 were detected when Ste5-Myc9 was maintained on a high-copy plasmid, and HA-Gβ was expressed at low ( Figure 4d , lane 1) and the association was not significantly altered by α factor (data not shown). When HA-Gβ was expressed at the lowest levels tested (Figure 4c, lanes 1,2) , however, Ste5-Myc9 preferentially bound to a form of Gβ that is induced by α factor. Thus, the interaction between Ste5 and Gβ may be pheromone dependent. Immunoprecipitations were performed as in (a) using the ste4∆ ste5∆ strain (S36) with STE5-Myc9 (pLS42) or ste5C180A-Myc9 (pLS43) and GAL1p-HA-STE4 (pYEE181). Negative controls were ste5∆ ste4∆ strains harboring control vector with HA-Gβ and control vector with Ste5-Myc9. Cells were grown in galactose medium for 2 h to express HA-Gβ, then either harvested directly (lanes 7-10), or pelleted and resuspended in 2% dextrose containing medium for an additional hour to repress the expression of HA-Gβ (lanes 1-6). The indicated samples had 50 nM α factor added for 10 min (lanes 2,4) . Significantly lower levels of HA-Gβ co-precipitated with Ste5C180A-Myc9 than with Ste5-Myc9 when HA-Gβ was expressed for 2 hours (Figure 4c, lane 8) . The reduction of HA-Gβ in the Ste5C180A-Myc9 immunoprecipitates was due to a loss of binding capacity, because equivalent levels of Ste5-Myc9 and Ste5C180A-Myc9 were present in the whole cell extracts. Even more dramatically, no binding was detected for Ste5C180A-Myc9 (or Ste5∆LIM-Myc9, which has residues 177-229 of the LIM domain deleted; data not shown) when HA-Gβ was expressed at lower levels ( Figure 4c, lanes 3,4) . Thus, signaling by Gβ to Ste11 correlated with the ability of Gβ to bind to Ste5 through the LIM domain. HA-Gβ and Ste5-Myc9 are overexpressed, it may not be physiologically relevant. Importantly, signal transduction was still blocked in these strains. Thus, while Gβ and Ste5 may associate through additional direct or indirect interactions, this association cannot substitute for the critical role of the LIM domain in signaling.
Ste5 binds preferentially to a form of Gb that has been hyperphosphorylated by a Ste5-dependent kinase
Our analysis revealed that Ste5 was preferentially associated with a hyperphosphorylated form of Gβ that arises in the presence of α factor or when Gβ is overexpressed. Previous work has demonstrated that Gβ is rapidly phosphorylated in the presence of α factor [31] . Gβ phosphorylation was demonstrated by the accumulation of slower migrating species (Figure 4b-e) that disappeared upon treatment with phosphatase (data not shown). The phosphorylated species accumulated when cells were treated with α factor or when Gβ was overexpressed and constitutively activated the pathway (Figure 4c -e; activation monitored by FUS1-LACZ, data not shown). That Ste5 preferentially associated with the phosphorylated form of Gβ was most dramatically shown under conditions in which Gβ was expressed at low levels. The Ste5-Myc9 immunoprecipitates only contained the phosphorylated form of Gβ, despite the fact that it was not readily detected in the whole cell extracts (Figure 4c ; similar results were found for α-factor induction times of 10, 20 and 30 minutes). Under conditions in which Gβ was expressed at higher levels, Ste5-Myc9 immunoprecipitates were always enriched for the phosphorylated form (Figure 4d,e) .
Gβ was not phosphorylated in the ste5C180A mutant, as shown by the absence of slower migrating species in pheromone-treated cells or in cells that had high levels of Gβ. Therefore, Gβ is phosphorylated by a protein kinase whose activity requires Ste5, suggesting that the kinase acts downstream of Ste5 in the pathway. Consistent with this, Gβ was still phosphorylated at low levels in ste20∆ and bem1∆ mutants, which have reduced levels of signal transduction due to blocks upstream of Ste11 (Figure 4e ).
Ste5C180A oligomerizes more efficiently than wild-type Ste5
The inability of Gβ to interact with Ste5C180A could be an indirect consequence of a defect in oligomerization. We addressed this issue in a series of experiments that directly measure oligomerization. As shown by two-hybrid analysis (Table 2) , LexA-Ste5(1-214) and LexA-Ste5(1-336) fusion proteins oligomerized with B42-Ste5 in diploid strains that did not express the endogenous STE5 gene. Thus, sequences sufficient for oligomerization of these fragments lie within the first 214 residues of Ste5. LexA-Ste5(1-214) and LexA-Ste5(1-336) each interacted Research Paper A pheromone-dependent Ste5-Gb interaction activates Ste11 Feng et al. 273
Figure 5
A functional LIM domain blocks G1 arrest when overexpressed. Aminoterminal fragments of Ste5 and Ste5C180A containing the indicated amino acids were expressed from the GAL1 promoter in wild-type (WT; EY1118), STE11-4 (EY1298) and STE11-4 ste20∆ (EY2022) strains. Halo assays were done in SC selective medium with 2% galactose and 3 µl 167 µM α factor. We tested the ability of Ste5-Myc9 and Ste5C180A-Myc9 to co-purify with GST-Ste5 and GST-Ste5C180A. GST-Ste5 associated with Ste5-Myc9 in a manner that was unaffected by α-factor addition (Figure 6a ). Ste5C180A-Myc9 oligomerized efficiently with GST-Ste5 (Figure 6b) . Furthermore, GST-Ste5C180A accumulated more oligomers than did GST-Ste5 as shown by the relative amounts of wild-type and mutant Mycepitope tagged proteins that co-purified with each one (Figure 6b ). The increased amount detected in the presence of the C180A mutation was not due to variations in the levels of the GST-tagged or Myc-tagged proteins in the cells, on the basis of immunoblots of whole cell extracts (data not shown). These findings agree with the two-hybrid results. They also fit with the observation that Ste5C180A had only a weak dominant-negative effect when overexpressed (data not shown), despite the fact that this protein binds the MAP kinase cascade enzymes. Furthermore, a GST-Ste5∆143-313 mutant, which completely lacks the LIM domain [19] , still oligomerized efficiently with both Ste5-Myc9 and Ste5C180A-Myc9 (Figure 6c ). This demonstrates that the LIM domain is not required for oligomerization. Thus, we conclude that the defect in binding between Gβ and Ste5C180A is not due to a block in the ability of Ste5C180A to oligomerize. The LIM domain may in fact negatively regulate Ste5 oligomerization.
Discussion

Binding of Ste5 to Gb through the LIM domain is essential for pheromone-dependent activation of Ste11 by Ste20
Taken together, our data argue that an interaction between Ste5 and Gβ through the putative LIM domain of Ste5 is specifically required for transmission of the pheromone signal from Gβ to Ste11. First, a point mutation within this domain (ste5C180A) causes a strong defect in the ability of Ste5 to associate with Gβ in vivo, although it does not abolish the ability of Ste5 to associate with Ste11, Ste7 and Fus3, or to oligomerize. Thus, in terms of all known physical interactions for Ste5, Ste5C180A is most severely defective in binding to Gβ. Second, the defect in binding to Gβ correlates with a complete block in pheromone-dependent signal transmission at the Gβ step of the pathway, even when the basal activity of Ste11 is high due to the STE11-4 mutation. By contrast, Ste5C180A is still able to facilitate signaling from Ste11 to Ste7 and the MAP kinases, which is consistent with its ability to bind to these enzymes. These data provide compelling evidence that Ste5 has two distinct functions, one required for pheromone-dependent activation of Ste11 through an interaction with Gβ, and a second required for signal relay from Ste11 to the MAP kinases that may occur through tethering the kinases.
Additional evidence argues that the putative LIM domain of Ste5 is responsible for all of the binding to Gβ that is required for signal transduction. First, a block in pheromone signaling and a defect in the Ste5-Gβ interaction that are similarly severe occur with a ste5∆LIM mutation, which deletes the LIM domain (data not shown). Second, two-hybrid analysis of Ste5 fragments overlapping the LIM domain shows that the LIM domain is necessary and sufficient to mediate the interaction with Ste5C180A oligomerizes more efficiently than wild-type Ste5. (a) Oligomerization between GST-Ste5 and Ste5-Myc9 is independent of α factor. A ste5∆ strain (EY1775) with GAL1p-GST-STE5 (pYEE170) and STE5-Myc9 (pSCEM21) was grown for 5 hs in galactose medium to induce the expression of GST-Ste5; 50 nM α factor was added for the indicated times. GST-Ste5 was purified from whole cell extracts with glutathione agarose as described in Materials and methods. (b) Ste5C180A-Myc9 forms more oligomers than Ste5-Myc9.
Samples were prepared as in (a) using a ste5∆ strain co-transformed with plasmids harboring GST-tagged and Myc-tagged forms of Ste5 (pYEE170, pLS29, pSCEM1, pSCEM22). A plasmid encoding GST was present in cells not expressing either one of the GST fusion proteins. (c) Deletion of the LIM domain does not block oligomerization. The same experiment was performed as in (b) except that oligomerization by GST-Ste5 was compared with oligomerization by GST-Ste5∆143-313 (encoded on pYEE166), which has the LIM domain deleted.
Gβ. Third, the ability of Ste5 amino-terminal fragments to interfere with Gβ-mediated signaling requires the presence of an intact LIM domain. While it is possible that auxiliary interactions may occur between Gβ and Ste5, as revealed under conditions in which both Gβ and Ste5C180A are overexpressed, these interactions are not sufficient to allow any signal transduction. We conclude that a functional binding event between the putative Ste5 LIM domain and Gβ is critical for the activation of Ste11 by mating pheromone.
Ste5 may have a localization function that allows Ste11 to be activated by Ste20
Our findings fit with a model in which the LIM domain of Ste5 functions to localize Ste11 to the plasma membrane where it can be activated by Ste20 in the presence of mating pheromone. Ste20 is known to localize beneath the plasma membrane through association with Cdc42 [8, 9] and is required for Ste11 function in vivo [5, 6] . Although Ste5C180A binds to Ste11, Ste7 and Fus3 and basally activates Ste11, its block in activation of Ste11 is not bypassed by the overexpression of Ste20, even when the basal activity of Ste11 is enhanced by mutation. The simplest interpretation of these results is that the association between Gβ and Ste5 is required for Ste20 to activate Ste11. This is consistent with the known requirement of Ste5 for Ste11 function [19, 24, 25] , the physical interaction between the two proteins [19, 20, 25] , and the finding that Ste5-Myc9 and a fusion between Ste5 and green fluorescent protein concentrate beneath the plasma membrane at the shmoo tip in cells that have been treated with α factor (S.K.M., L.Y.S. and E.A.E., unpublished observations).
Our results also suggest that Ste5 mediates activation of Ste11 through another function that is distinct from simple binding to Gβ. Ste20 is unable to activate Ste11 in strains that overexpress both Gβ and Ste5C180A, despite an association between these two proteins. One interpretation of these results is that, in addition to binding to Gβ, Ste5 must undergo a specific conformational change or physically mediate a functional interaction between Ste11 and Ste20 that is required for the activation event.
The Ste5 LIM domain also mediates a Ste20-independent signaling event
We extend previous work suggesting that Gβ mediates a second signal distinct from activation of Ste20 that is required to activate Ste11 [21] . Gβ is still phosphorylated in a manner dependent on α factor and Ste5 in a ste20 deletion strain, demonstrating a specific signaling event at the Gβ step that requires Ste5 but not Ste20. The fact that a ste5C180A mutant is more defective in signaling than a ste20∆ mutant, and overexpression of an intact LIM domain blocks signaling in a ste20∆ STE11-4 strain, provides strong evidence that the LIM domain of Ste5 is required for this auxiliary signaling event. What mediates this parallel pathway of activation? One possibility is that Ste5 positively regulates Ste11 through allosteric interactions. Ste11 may dimerize [19, 25] , suggesting one level of regulation distinct from phosphorylation that could be influenced by Ste5. It is conceivable that Ste11 activity is enhanced by Ste5 oligomerization, as has been shown to be the case for Raf-1 [32, 33] . In addition, other proteins may function with Ste20 to regulate Ste11, including Ste50 [16] , Ste21 [34], or a kinase with a functional overlap with Ste20.
Binding of Gb to Ste5 is not essential for oligomerization
Previous work suggests that oligomerization of Ste5 is required for signal transduction [27] . We demonstrate here that the LIM domain is not required for oligomerization of Ste5. On the basis of two-hybrid analysis, oligomerization requires amino acids within the first 176 residues of Ste5 that lie to the amino-terminal side of the LIM domain. The fact that both Ste5C180A and a Ste5∆143−313 mutant, which is deleted for the LIM domain, oligomerize efficiently argues compellingly that oligomerization is required for another step in signal transduction. Several lines of evidence suggest that oligomerization may stimulate basal signal transduction from Ste11 to the MAP kinases. First, α factor has no effect on the amount of oligomers detected for either wild-type Ste5 or Ste5C180A, in contrast to its effect on binding of Ste5 to Gβ. Second, fusion of a protein that dimerizes (GST) to Ste5 increases basal signaling, but does not enhance the response to α factor. Third, fusion of GST to Ste5C180A stimulates the basal signaling capacity of this protein, but does not suppress the block in α-factor-dependent signaling. Ste5C180A oligomerizes somewhat more efficiently than wild-type Ste5, suggesting that the LIM domain may inhibit oligomerization. Such negative regulation might prevent inappropriate activation of the MAP kinase cascade in the absence of stimulus. Binding of Gβ to Ste5 may relieve this negative regulation, and at the same time activate Ste5.
Our conclusions disagree in part with those of Inouye et al. [29] , who analyzed a similar ste5 mutant, ste5177A180A, with two mutations in the LIM domain. Inouye et al. [29] conclude, as we do, that residues within the LIM domain are essential for binding to Gβ. However, these workers also conclude that the LIM domain is required for oligomerization, and propose that Gβ binding mediates Ste5 oligomerization. Inouye et al. [29] argue that Ste5177A180A does not oligomerize on the basis of interallelic complementation tests. While it is possible that these indirect genetic tests are not reliable, they may reflect a true defect in oligomerization. If so, then we would have to conclude that the double mutation causes additional conformational changes that affect oligomerization, perhaps involving residues that are amino terminal to the LIM domain and closest to the Cys177→Ala mutation. Nevertheless, the fact that we find that both Ste5C180A and Ste5∆143-313, which lacks the LIM domain (and cysteine 177), still oligomerize in a direct biochemical test demonstrates that Gβ binding is not required for oligomerization.
Inouye et al. [29] claim further support for their model with the finding that fusion of GST to Ste5177A180A restores mating to a Gβ mutant. However, we find that GST may create a Ste5 'hypermorph' that increases basal signaling and simply bypasses Gβ function. While it is possible that GST enhances the activity of Ste5 through its own ability to dimerize [29] , further work is required to determine whether Gβ regulates the assembly of Ste5 oligomers.
Understanding the role of oligomerization in signaling is likely to be complex, as proper regulation of both association and dissociation of Ste5 oligomers may be critical for signal transduction. Preliminary analysis of a hyperactive STE5 HYP2 (ste5T52M [35] ) mutant suggests that this gainof-function is due to reduced levels of oligomers, rather than enhanced binding to Gβ, Ste11, Ste7, or Fus3 (Y.F., B. Satterberg and E.A.E., unpublished observations). In addition, overexpression of GST-Ste5, which may accumulate more oligomers than normal, blocks G1 arrest and reduces maximal levels of FUS1 activation in a wild-type strain (Y.F. and E.A.E., unpublished observations). Thus, Ste5 complex formation may be a transient event, and mutations that affect either complex assembly or disassembly may have related phenotypes.
Ste5 may bind with highest affinity to free Gb
We demonstrate that under conditions in which Gβ is not overexpressed, Ste5 binds to a form of Gβ that only exists in the presence of α factor. This finding strongly suggests that the interaction between Gβ and Ste5 is a pheromone-dependent event and that Ste5 binds preferentially to free Gβ that has been liberated from inhibition by Gα. Previous work has suggested that the interaction between Gβ and Ste5 is pheromone independent [26, 29] . Gβ was overexpressed in these studies, however, creating conditions that may have masked the pheromone dependence. Our findings are consistent with the fact that the LIM domain that mediates the binding between Ste5 and Gβ is required for pheromone-dependent activation of Ste11.
We find that Ste5 preferentially associates with the hyperphosphorylated form of Gβ. One could argue that the absence of binding between Gβ and Ste5C180A is an indirect consequence of the block in phosphorylation of Gβ. This is highly unlikely, however, as Gβ phosphorylation is not required for signal transduction [31] , and is mediated by a kinase that acts downstream of Ste5 and requires the Gβ-Ste5 signal for activity (Figure 4) . Thus, Ste5 most probably binds to free Gβ that has not been phosphorylated, consistent with the ability of Ste5 to interact with Gβ in a two-hybrid assay in a ste11∆ mutant that lacks pathway activity ( Table 2) .
Phosphorylation of Gβ is believed to attenuate signal transduction [31] . Fus3 attenuates signal transduction [1] and phosphorylates other upstream signaling components [18, 19, 36] , raising the possibility that it is the Gβ kinase. This is consistent with the fact that Fus3 is cytoplasmic (K-Y. Choi, J.A. Kranz, S.M. Mahanty and E.A.E., unpublished observations), requires Ste5 for kinase activity [18] , and binds to a region of Ste5 that is next to the LIM domain [19] , near the Ste5-Gβ binding interface. A coupling between Gβ-Ste5 binding and Fus3 phosphorylation would provide a way to tightly regulate signaling at an early rate-limiting step in the pathway.
Materials and methods
Strains and plasmids
A table showing the yeast strains used in this study is available as Supplementary material (published with this paper on the internet). All integrations were confirmed by Southern analysis. The functional Ste5-Myc9 has 9 tandem c-Myc monoclonal 9E10 epitopes before the Ste5 stop codon (S.K.M., L.Y.S., F. Farley and E.A.E., unpublished).
HIS3 CEN) and pKC11 (pGAL1-STE11M ADE2 CEN) are described elsewhere [13, 18, 19, 21, 37] . Descriptions of all other plasmids are available as Supplementary material (published with this paper on the internet).
Pheromone response assays
We measured α-factor sensitivity by halo assay as described [38] , using 50 µl overnight culture of yeast cells. The α-factor peptide (synthesized by C. Dahl, Harvard Medical school), was dissolved in 90% methanol and stored at -20°C. All halo assays were done at least in duplicate, using 3µl 167 µM synthetic α factor. Qualitative patch mating assays were done as described for 4-6 h at 30°C [38] using YEP plates containing dextrose or galactose depending on the strains tested. FUS1 transcription was assayed using a FUS1-LACZ fusion (pJB207). Cells were grown to an A 600 of 0.4, then they were induced by 50 nM α factor for 90 min. Extracts were prepared and β-galactosidase activity was measured as described [13] .
Two-hybrid analysis
Plasmids encoding B42 and LexA fusion proteins were co-transformed into strain AMR70. Four independent transformants were pregrown in selective SC media containing 2% raffinose to an A 600 of 0.8 to 1.2, then cells were diluted to an A 600 of 0.25 in selective media containing 2% galactose, grown for an additional 5 h, harvested, and extracts prepared and assayed for β-galactosidase activity as described [19] ; 30-50 µg protein was typically assayed.
Co-immunoprecipitations
Strains containing genes under the control of the GAL1 promoter were pregrown in selective SC media with 2% raffinose to an A 600 of 1.0-1.3. Cells were pelleted and resuspended in selective SC media containing 2% galactose at an A 600 of 0.3 to 1.0, then further grown for 1-7 h and harvested either at an A 600 of ~1.2 or grown for an additional hour in selective SC media containing 2% dextrose. Where indicated, 50nM α factor was added 10-20 min before the cells were collected. After being washed once with ice-chilled deionized water, cells were frozen on dry ice and stored at -80°C for protein extraction. Whole cell extracts were made as described [14] , with an additional back-extraction in precipitation buffer [26] containing 2 mM PMSF, 5 µg/ml each of pepstatin A, leupeptin, chymostatin and antipain. Protein concentration was determined with Bio-Rad protein assay (BioRad). Whole cell protein (5-10 mg) was used to detect the interactions between Ste5-Myc9 and HA-Gβ by co-immunoprecipitating in 1 ml precipitation buffer with 3 µg monoclonal antibody 9E10, or a 1:400 dilution of polyclonal rabbit anti-HA antibody (BAbCO) on ice for 1.5-2 h. Immune complexes were collected by incubating with 20 µg Protein-A-sepharose (Phamacia Biotech) at 4°C for 1 h, then washed five times with binding buffer. Samples were resuspended in SDS-PAGE sample buffer and analyzed by immunoblotting. Extracts used for detecting dimerization of Ste5-Myc9 and GST-Ste5 were made similarly, using modified H buffer [14] containing 0.07% Triton-X 100 and 100 mM NaCl. For glutathione resin binding experiments, 250 µg protein was used. Binding of GST-Ste5 to glutathione agarose was performed at 4°C for 3 h and complexes were washed three times with modified H buffer containing 150 mM NaCl and once with the same buffer containing 500 mM NaCl. Immunoblotting was performed [14, 18] with the ECL system (Amersham).
Supplementary material
Details of how the plasmids described in this study were generated and tables showing the yeast strains and plasmids used are published with this paper on the internet. 
Materials and methods
Plasmids
The ste5C180A gene was created by in vivo site-directed mutagenesis [S1]. A PCR product was made using 5′ primer CCTTTTTGAATG-CTTCTTGTACGCTATCTGACGAGCCTATTTCTA, and 3′ primer GGAAAGCGGGACTGAGGTGT. This PCR product, which overlaps the MscI site, and contains the C180A mutation and a novel NheI site, was co-transformed into a ste5∆ strain (EY1775) with linearized plasmid pYBS138. NheI was used to diagnose incorporation of the desired mutation. A ste5C180A-containing plasmid (pEK1) was recovered then sequenced. Two-hybrid analysis was done using previously published plasmids [19] . For B42-Gβ (pLS3), the BamHI and SalI fragment of pYEE160 [13] containing the Gβ coding region was cloned into the BamHI site of pJG4-5 by blunt-end ligation at the SalI site. LexA-Ste5(1-176), (1-214), (1-230) and (1-336) were made by PCR amplifying the amino-terminal region of Ste5 using a 5′ primer GCGGAATTCGGATCCATGATGGAAACTCCTAC, in combination with 3′ primers CGCTAGGATCCTAAGAAGCATTCAAAAAG, AGTGGATCCTTAAGTGGTGCCAAA, GCGATGGATCCTATTTAC-ATTTGGTCAA, and AGTGGATCCTTAAATTCTTCTGTGCCCCAG, respectively. The PCR products were digested with BamHI and cloned into the BamHI site of pEG202 (pLS30, pLS8, pLS31 and pLS11, respectively, for Ste5 and pLS9, pLS32, pLS12, pLS7 and pLS10, respectively, for Ste5C180A). These PCR products were also cloned into the BamHI site of plasmid ZM43 (URA3 CEN) under the control of the GAL1 promoter (pLS33, pLS34, pLS35, pLS36, pLS38 and pLS39, respectively). Table S1 Yeast strains used in this study. (GATCCAGCGTAGTCTGGGACGTCGTATGGGTAA-TG), filling in the ends with Klenow, and then PCR-amplifying with 5′ oligo His6-HA1b (GCGCGAATTCAGATCTATGGCACATC) and 3′ oligo His6-HA1b (GCGCGTCGACGGATCCAGCGTAGTCT). This PCR product was digested by BglII and BamHI and ligated into the BamHI site of pL19. GST-STE5C180A (pLS29) was constructed by digesting GST-STE5 (pYEE170) completely with SpeI, and partially by KpnI, releasing the wild-type STE5 KpnI-SpeI fragment and replacing it with the corresponding ste5C180A fragment. The pGAL1-STE20 LEU2 CEN (ZM44Ste20) and pGAL1-STE50 LEU2 CEN (ZM44Ste50) plasmids will be described elsewhere. All PCR amplification was done with Pfu DNA polymerase (Stratagene) and all products were either sequenced or confirmed by examination of multiple independent clones. Table S2 Plasmids used in this study.
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